Cargando…
IQGAP2 acts as an independent prognostic factor and is related to immunosuppression in DLBCL
BACKGROUND: Almost one-third of patients with diffuse large B-cell lymphoma (DLBCL) cannot be cured with initial therapy and will eventually succumb to the disease. Further elaboration of prognostic markers of DLBCL will provide therapeutic targets. IQ motif-containing GTPase activating protein 2 (I...
Autores principales: | Tang, Tianjiao, Wang, Jing, Zhang, Lidan, Cheng, Ying, Saleh, Laura, Gu, Yanni, Zhang, Hongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152057/ https://www.ncbi.nlm.nih.gov/pubmed/34034707 http://dx.doi.org/10.1186/s12885-021-08086-y |
Ejemplares similares
-
RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3
por: Chen, Chih-Cheng, et al.
Publicado: (2021) -
The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers
por: Song, Fei, et al.
Publicado: (2023) -
Comprehensive Analyses of the Immunological and Prognostic Roles of an IQGAP3AR/let-7c-5p/IQGAP3 Axis in Different Types of Human Cancer
por: Yuan, Yixiao, et al.
Publicado: (2022) -
IQGAP1 and IQGAP2 are Reciprocally Altered in Hepatocellular Carcinoma
por: White, Colin D, et al.
Publicado: (2010) -
Endogenous IQGAP1 and IQGAP3 do not functionally interact with Ras
por: Morgan, Chase J., et al.
Publicado: (2019)